ArticleSarcoma2019

Analysis of the CDK4/6 Cell Cycle Pathway in Leiomyosarcomas as a Potential Target for Inhibition by Palbociclib.

Michael J Böhm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.